申请人:Hurley Laurence H.
公开号:US20130302303A1
公开(公告)日:2013-11-14
Protein kinase inhibitors are disclosed having utility in the treatment of protein kinase-mediated diseases and conditions, such as cancer. The compounds of this invention have the following structure:
including steroisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein A is a ring moiety selected from:
and wherein R
1
, R
2
, R
3
, X, Z, L1, Cycl1, L2 and Cycl2 are as defined herein. Also disclosed are compositions containing a compound of this invention, as well as methods relating to the use thereof.
本发明揭示了具有在蛋白激酶介导的疾病和病症(如癌症)治疗中的用途的蛋白激酶抑制剂。本发明的化合物具有以下结构:包括立体异构体,前药和其药学上可接受的盐,其中A是从以下环基团中选择的环基团:其中R1、R2、R3、X、Z、L1、Cycl1、L2和Cycl2如本文所定义。本发明还揭示了含有本发明化合物的组合物,以及与其使用相关的方法。